Literature DB >> 6362548

Vitamin D metabolism and function during pregnancy and the neonatal period.

M E Bruns, D E Bruns.   

Abstract

Recent evidence suggests that vitamin D plays an important role in calcium homeostasis during pregnancy and early extrauterine life. Vitamin D is metabolized by successive hydroxylations to 25-hydroxyvitamin D and then to 1,25-dihydroxyvitamin D, the most potent known metabolite of the vitamin. During pregnancy, the concentrations of this metabolite in maternal serum increase in parallel with the increased need to absorb dietary calcium. 1,25-Dihydroxyvitamin D is produced in the fetoplacental unit as well as in the maternal kidneys. Receptors for 1,25-dihydroxyvitamin D appear to be present in the placenta suggesting that the placenta may be a target for vitamin D action. Developmental changes in vitamin D metabolism and action have been documented in the neonate as well as in the mother and fetus. Clinical studies indicate that adequate vitamin D intake is important during pregnancy. Administration of vitamin D or its metabolites appears to be useful in the treatment of neonatal disorders.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6362548

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  3 in total

1.  1alpha-hydroxylase and innate immune responses to 25-hydroxyvitamin D in colonic cell lines.

Authors:  Venu Lagishetty; Rene F Chun; Nancy Q Liu; Thomas S Lisse; John S Adams; Martin Hewison
Journal:  J Steroid Biochem Mol Biol       Date:  2010-02-10       Impact factor: 4.292

2.  Inverse association between maternal 25OHD level and cord GLP-1/GIP concentrations.

Authors:  Shimpei Niwa; Hidetoshi Mezawa; Naoaki Kobayashi; Hiroyuki Ida; Mitsuyoshi Urashima
Journal:  Pediatr Res       Date:  2015-12-09       Impact factor: 3.756

3.  Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond.

Authors:  Farhan Cyprian; Eleftheria Lefkou; Katerina Varoudi; Guillermina Girardi
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.